EarningsQ3 2024 Earnings Report

Alnylam Pharma (DUL) Q3 2024 Earnings Report

0 Followers

CH:DUL Q3 2024 EPS Results

Actual EPS-CHF0.72

Consensus EPS-CHF0.76

Beat/MissBeat by +CHF0.04

One Year Ago EPSCHF0.96

Actual RevenueCHF416.84M

Expected RevenueCHF443.47M

Beat/MissMissed by -CHF26.62M

YoY Revenue Growth-33.26%

QuarterQ3 2024

Date10/31/2024

TimeBefore Open

Conference CallThursday, October 31, 2024

CH:DUL Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

CH:DUL Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	1.46 / -	1.531	―
Jul 30, 2026	2026 (Q2)	1.36 / 1.01	-0.424	337.25% (+1.43)
Apr 30, 2026	2026 (Q1)	0.73 / 1.26	-0.366	443.18% (+1.62)
Feb 12, 2026	2025 (Q4)	0.96 / 0.68	-0.541	226.15% (+1.22)
Oct 30, 2025	2025 (Q3)	0.47 / 1.53	-0.724	311.49% (+2.26)
Jul 31, 2025	2025 (Q2)	-0.45 / -0.42	-0.108	-292.31% (-0.32)
May 01, 2025	2025 (Q1)	-0.74 / -0.37	-0.433	15.38% (+0.07)
Feb 13, 2025	2024 (Q4)	-0.49 / -0.54	-0.915	40.91% (+0.37)
Oct 31, 2024	2024 (Q3)	-0.76 / -0.72	0.957	-175.65% (-1.68)
Aug 01, 2024	2024 (Q2)	-0.89 / -0.11	-1.839	94.12% (+1.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed